Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1979 Jan;41(1):23–27. doi: 10.1136/hrt.41.1.23

Haemostatic defects in cyanotic congenital heart disease.

P Henriksson, G Värendh, N R Lundström
PMCID: PMC482008  PMID: 426953

Abstract

An investigation of defects of the haemostatic mechanism in 41 children with cyanotic congenital heart disease concluded that such abnormalities were common and normally involved factors synthesised in the liver, that is the vitamin K dependent factors (rothrombin, factors VII and IX) and factor V. No evidence was found of activation of the coagulation or fibrinolytic systems. The defects can be explained by deficient synthesis resulting from systemic hypoxia as well as from sluggishness of the local microcirculation caused by high blood viscosity. Vitamin K parenterally had no demonstrable effect. Replacement of these factors, possibly combined with measures to improve the microcirculation, therefore, appears to be the appropriate treatment.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abildgaard U., Gravem K., Godal H. C. Assay of progressive antithrombin in plasma. Thromb Diath Haemorrh. 1970 Oct 31;24(1):224–229. [PubMed] [Google Scholar]
  2. Abrahamsen A. F. A modification of the technique for 51Cr-labelling of blood platelets giving increased circulating platelet radioactivity. Scand J Haematol. 1968;5(1):53–63. doi: 10.1111/j.1600-0609.1968.tb01718.x. [DOI] [PubMed] [Google Scholar]
  3. Appleyard W. J., Cottom D. G. Effect of asphyxia on thrombotest values in low birthweight infants. Arch Dis Child. 1970 Oct;45(243):705–707. doi: 10.1136/adc.45.243.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BAHNSON H. T., ZIEGLER R. F. A consideration of the causes of death following operation for congenital heart disease of the cyanotic type. Surg Gynecol Obstet. 1950 Jan;90(1):60–76. [PubMed] [Google Scholar]
  5. BERTHRONG M., SABISTON D. C., Jr Cerebral lesions in congenital heart disease, a review of autopsies on 162 cases. Bull Johns Hopkins Hosp. 1951 Nov;89(5):384–406. [PubMed] [Google Scholar]
  6. Bleyl U., Höpker W. W. Disseminierte intravasale Gerinnung und pulmonale hyaline Membranen bei connatalen cyanotischen Herzfehlern. Virchows Arch A Pathol Pathol Anat. 1970;350(3):225–239. [PubMed] [Google Scholar]
  7. Brodsky I., Gill D. N., Lusch C. J. Fibrinolysis in congenital heart disease. Preoperative treatment with epsilon-aminocaproic acid. Am J Clin Pathol. 1969 Jan;51(1):51–57. doi: 10.1093/ajcp/51.1.51. [DOI] [PubMed] [Google Scholar]
  8. Cottrill C. M., Kaplan S. Cerebral vascular accidents in cyanotic congenital heart disease. Am J Dis Child. 1973 Apr;125(4):484–487. doi: 10.1001/archpedi.1973.04160040010003. [DOI] [PubMed] [Google Scholar]
  9. Dennis L. H., Stewart J. L., Conrad M. E. Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease. Lancet. 1967 May 20;1(7499):1088–1089. doi: 10.1016/s0140-6736(67)92655-4. [DOI] [PubMed] [Google Scholar]
  10. Ekert H., Gilchrist G. S., Stanton R., Hammond D. Hemostasis in cyanotic congenital heart disease. J Pediatr. 1970 Feb;76(2):221–230. doi: 10.1016/s0022-3476(70)80166-4. [DOI] [PubMed] [Google Scholar]
  11. FERENCZ C. The pulmonary vascular bed in tetralogy of Fallot. I. Changes associated with pulmonic stenosis. Bull Johns Hopkins Hosp. 1960 Feb;106:81–99. [PubMed] [Google Scholar]
  12. GANS H., KRIVIT W. Problems in hemostasis during and after open-heart surgery. VI. Over-all changes in blood coagulation mechanism. JAMA. 1962 Jan 13;179:145–148. doi: 10.1001/jama.1962.03050020000006d. [DOI] [PubMed] [Google Scholar]
  13. Ganrot P. O., Niléhn J. E. Immunochemical determination of human plasminogen. Clin Chim Acta. 1968 Nov;22(3):335–340. doi: 10.1016/0009-8981(68)90033-8. [DOI] [PubMed] [Google Scholar]
  14. Ghosh M. L., Emery J. L. Hypoxia and asymmetrical fibrosis of the liver in children. Gut. 1973 Mar;14(3):209–212. doi: 10.1136/gut.14.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldschmidt B. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease. Acta Paediatr Acad Sci Hung. 1970;11(2):135–139. [PubMed] [Google Scholar]
  16. Goldschmidt B., Sarkadi B., Gárdos G., Matlary A. Platelet producton and survival in cyanotic congenital heart disease. Scand J Haematol. 1974;13(2):110–115. doi: 10.1111/j.1600-0609.1974.tb00243.x. [DOI] [PubMed] [Google Scholar]
  17. Gralnick H. R. Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease. Lancet. 1970 Jun 6;1(7658):1204–1205. doi: 10.1016/s0140-6736(70)91789-7. [DOI] [PubMed] [Google Scholar]
  18. Gross S., Keefer V., Liebman J. The platelets in cyanotic congenital heart disease. Pediatrics. 1968 Oct;42(4):651–658. [PubMed] [Google Scholar]
  19. HARTMANN R. C. A hemorrhagic disorder occurring in patients with cyanotic congenital heart disease. Bull Johns Hopkins Hosp. 1952 Jul;91(1):49–67. [PubMed] [Google Scholar]
  20. Hedner U., Henriksson P., Nilsson I. M. Factor XIII in a clinical material. Scand J Haematol. 1975 Apr;14(2):114–119. doi: 10.1111/j.1600-0609.1975.tb00303.x. [DOI] [PubMed] [Google Scholar]
  21. Hedner U., Nilsson I. M., Bergentz S. E. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo. Thromb Haemost. 1976 Apr 30;35(2):386–395. [PubMed] [Google Scholar]
  22. Hedner U., Nilsson I. M., Jacobsen C. D. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Scand J Clin Lab Invest. 1970 Jun;25(4):329–336. doi: 10.3109/00365517009046213. [DOI] [PubMed] [Google Scholar]
  23. Henriksson P., Holmberg L. Factor VIII activity and antigen in sick newborns with pathological proteolysis in blood. Acta Paediatr Scand. 1978 Jan;67(1):83–87. doi: 10.1111/j.1651-2227.1978.tb16281.x. [DOI] [PubMed] [Google Scholar]
  24. Holmberg L., Nilsson I. M. Immunologic studies in haemophilia A. Scand J Haematol. 1973;10(1):12–16. doi: 10.1111/j.1600-0609.1973.tb00032.x. [DOI] [PubMed] [Google Scholar]
  25. Ihenacho H. N., Fletcher D. J., Breeze G. R., Stuart J. Consumption coagulopathy in congenital heart-disease. Lancet. 1973 Feb 3;1(7797):231–234. doi: 10.1016/s0140-6736(73)90069-x. [DOI] [PubMed] [Google Scholar]
  26. Iolster N. J. Blood coagulation in children with cyanotic congenital heart disease. Acta Paediatr Scand. 1970 Sep;59(5):551–557. doi: 10.1111/j.1651-2227.1970.tb16807.x. [DOI] [PubMed] [Google Scholar]
  27. Isacson S., Nilsson I. M. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand. 1972;138(4):313–319. [PubMed] [Google Scholar]
  28. Johnson C. A., Abildgaard C. F., Schulman I. Absence of coagulation abnormalities in children with cyanotic congenital heart-disease. Lancet. 1968 Sep 21;2(7569):660–662. doi: 10.1016/s0140-6736(68)92508-7. [DOI] [PubMed] [Google Scholar]
  29. KUMMER H., GURTNER H. P., BUCHER U. THROMBOCYTOPENIE BEI CHRONISCHEM COR PULMONALE UND CYANOTISCHEN HERZVITIEN. Schweiz Med Wochenschr. 1964 Sep 19;94:1334–1336. [PubMed] [Google Scholar]
  30. Karaca M., Nilsson I. M., Hedner U. Quantitative determination of platelet fibrinogen. J Lab Clin Med. 1971 Mar;77(3):485–489. [PubMed] [Google Scholar]
  31. Komp D. M., Sparrow A. W. Polycythemia in cyanotic heart disease--a study of altered coagulation. J Pediatr. 1970 Feb;76(2):231–236. doi: 10.1016/s0022-3476(70)80167-6. [DOI] [PubMed] [Google Scholar]
  32. Kontras S. B., Bodenbender J. G., Craenen J., Hosier D. M. Hyperviscosity in congenital heart disease. J Pediatr. 1970 Feb;76(2):214–220. doi: 10.1016/s0022-3476(70)80165-2. [DOI] [PubMed] [Google Scholar]
  33. Kontras S. B., Sirak H. D., Newton W. A., Jr Hematologic abnormalities in children with congenital heart disease. JAMA. 1966 Feb 21;195(8):611–615. [PubMed] [Google Scholar]
  34. MCFARLANE A. S. Labelling of plasma proteins with radioactive iodine. Biochem J. 1956 Jan;62(1):135–143. doi: 10.1042/bj0620135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Markarian M., Lindley A., Jackson J. J., Bannon A. Coagulation factors in pregnant women and premature infants with and without the respiratory distress syndrome. Thromb Diath Haemorrh. 1967 May 31;17(3-4):585–594. [PubMed] [Google Scholar]
  36. Maurer H. M. Hematologic effects of cardiac disease. Pediatr Clin North Am. 1972 Nov;19(4):1083–1093. doi: 10.1016/s0031-3955(16)32784-5. [DOI] [PubMed] [Google Scholar]
  37. McKay D. G. Progress in disseminated intravascular coagulation. II. Calif Med. 1969 Oct;111(4):279–290. [PMC free article] [PubMed] [Google Scholar]
  38. NILSSON I. M., BLOMBACK M., RAMGREN O. Haemophilia in Sweden. I. Coagulation studies. Acta Med Scand. 1961 Dec;170:665–682. [PubMed] [Google Scholar]
  39. NILSSON I. M., BLOMBACK M., VON FRANCKEN I. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand. 1957 Oct 30;159(1):35–57. doi: 10.1111/j.0954-6820.1957.tb00532.x. [DOI] [PubMed] [Google Scholar]
  40. NILSSON I. M., OLOW B. Determination of fibrinogen and fibrinogenolytic activity. Thromb Diath Haemorrh. 1962 Nov 15;8:297–310. [PubMed] [Google Scholar]
  41. Ohshima N. Hemorheology in hyper- and hypoviscosity syndrome. Thromb Res. 1976 May;8(2 Suppl):9–16. doi: 10.1016/0049-3848(76)90042-6. [DOI] [PubMed] [Google Scholar]
  42. Pandolfi M., Bjernstad A., Nilsson I. M. Technical remarks on the microscopical demonstration of tissue plasminogen activator. Thromb Diath Haemorrh. 1972 Feb 29;27(1):88–98. [PubMed] [Google Scholar]
  43. Perlick E., Ursinus K., Ursinus W., Hofmann G. Pathogenese, Prophylaxe und Therapie der Blutstillungsstörungen bei kongenitalen Kardiopathien. Z Gesamte Inn Med. 1971 Sep 1;26(17):545–551. [PubMed] [Google Scholar]
  44. Pike G. J., Turner R. L., Manohitharajah S. M., Deverall P. B. Fibrinolysis in cyanotic and acyanotic children before and after open intracardiac operations with the Bently Temptrol oxygenator. J Thorac Cardiovasc Surg. 1975 Jun;69(6):922–926. [PubMed] [Google Scholar]
  45. Terplan K. L. Patterns of brain damage in infants and children with congental heart disease. Association with catheterization and surgical procedures. Am J Dis Child. 1973 Feb;125(2):176–185. [PubMed] [Google Scholar]
  46. WELLS R. E., Jr, DENTON R., MERRILL E. W. Measurement of viscosity of biologic fluids by cone plate viscometer. J Lab Clin Med. 1961 Apr;57:646–656. [PubMed] [Google Scholar]
  47. Waldman J. D., Czapek E. E., Paul M. H., Schwartz A. D., Levin D. L., Schindler S. Shortened platelet survival in cyanotic heart disease. J Pediatr. 1975 Jul;87(1):77–79. doi: 10.1016/s0022-3476(75)80073-4. [DOI] [PubMed] [Google Scholar]
  48. Wedemeyer A. L., Edson J. R., Krivit W. Coagulation in cyanotic congenital heart disease. Am J Dis Child. 1972 Nov;124(5):656–660. doi: 10.1001/archpedi.1972.02110170034005. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES